- Home
- SLS vs AMSF Comparison
SLS vs AMSF Comparison
Compare SLS & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLS | AMSF |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.7M | 616.3M |
| IPO Year | 2007 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SLS | AMSF |
|---|---|---|
| Price | $4.37 | $32.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $10.00 | ★ $50.33 |
| AVG Volume (30 Days) | ★ 6.6M | 187.6K |
| Earning Date | 03-19-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 8.01% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 2.47 |
| Revenue | N/A | ★ $317,252,000.00 |
| Revenue This Year | N/A | $8.06 |
| Revenue Next Year | $67.40 | $6.34 |
| P/E Ratio | ★ N/A | $13.35 |
| Revenue Growth | N/A | ★ 2.66 |
| 52 Week Low | $0.95 | $32.00 |
| 52 Week High | $6.14 | $53.27 |
Technical Indicators
Market Signals| Indicator | SLS | AMSF |
|---|---|---|
| Relative Strength Index (RSI) | 43.93 | 37.75 |
| Support Level | $3.35 | $32.08 |
| Resistance Level | $5.01 | $33.74 |
| Average True Range (ATR) | 0.49 | 0.69 |
| MACD | -0.12 | 0.13 |
| Stochastic Oscillator | 0.32 | 34.07 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.